Today’s top gainers include the company Biogen Inc. (NASDAQ:BIIB) which is in the industry Biotechnology, gaining -1.05% today. In the last week its performance is 0.69%, and -4.19% for the past quarter. Currently, Biogen Inc., BIIB has a target price of 313.86, so today’s gain of -1.05% is a significant step towards its target price. The GAP today is therefore -0.04%.
Biogen Inc. (NASDAQ:BIIB), has a market cap of 58557, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 89.90%.
At the current price of 271.16, it has a dividend yield of *TBA, and its target price is 313.86. This is with a profit margin of 32.30%, and total debt/equity of 0.54. Biogen Inc. (NASDAQ:BIIB) has a P/E of 16.03, as well as a forward P/E of 12.16.
With a current EPS of 16.91, and a forecasted EPS growth for next year at 6.49%,Biogen Inc. (NASDAQ:BIIB) has had a EPS growth for the past five years at 27.40%. For the next five years EPS growth is projected to be 6.62%.
Performance for the year is -0.64%. Since its IPO date on 9/17/1991, the total performance to date is -4.38%.
Volume today for Biogen Inc. (NASDAQ:BIIB), is 1379500, while its average volume is 1659.11. Whilst the total gain today was -1.05%, it did have a day high of -9.01%.
Volatility for this week has been at 1.53%, and 1.63% for the month. The 52-week low for Biogen Inc., BIIB has been 21.59%, while the 52-week-high has reached -18.73%.
Looking at its return of investments, which is 21.00%, and its return on assets is 17.00%. Biogen Inc. (NASDAQ:BIIB) has an operating margin of 45.00%. With a sales growth of 1.20% quarter over quarter. Bearing in mind that Biogen Inc., BIIB is in the sector Healthcare, its long-term debt/equity is 0.54, and has a current ratio of 2.6 and 2.3 for quick ratio.
So what is the value of Biogen Inc.? Well its PEG is 2.42, and the P/S is 5.11, along with a P/B of 4.84. Meanwhile it has a p/cash of 11.96.